International Journal of Molecular Veterinary Research 2024, Vol.14, No.1, 1-8 http://animalscipublisher.com/index.php/ijmvr 6 Through these comprehensive strategies for managing secondary infections, complications can be effectively controlled, improving the quality of life for cats. Simultaneously, it provides support and guidance to pet owners in addressing this challenge collaboratively. 5 Successful Treatment Case Study 5.1 Case description Kangkang, a typical Chinese LiHua cat, is housed at the Hainan Tropical Agriculture Resources Research Institute. He resides in a 400-square-meter indoor space on the third floor of the institute's office building. Kangkang is a male cat, born on July 17, 2020, and has been neutered. Despite receiving complete vaccinations and regular deworming, he exhibited symptoms such as hematuria, weight loss, oral ulcers, and gingival edema on October 22, 2023. His weight decreased from 7.5 kilograms to 6.6 kilograms. Preliminary examination revealed abdominal tenderness when touching Kangkang's abdomen, and there was noticeable swelling in the oral and pharyngeal regions. The diagnostic process involved clinical symptom observation and a five-fluorescent PCR test for feline respiratory diseases. The results indicated that Kangkang was infected with a cup-shaped virus, with a Ct value of 20.5, confirming a positive reaction. 5.2 Analysis of the treatment process The treatment plan encompassed several aspects: Initial assessment, including a comprehensive physical examination and evaluation of vital signs and overall health. Laboratory tests, including CT scans, blood routine, urinalysis, and specific FCV detection. Clinical treatment, involving analgesic, anti-inflammatory therapy, antiviral treatment targeting FCV, and concurrent supportive care. 5.3 Treatment methods employed Bayer Baytril Injection: Dosage of 1 mL, subcutaneous injection, once daily. Meloxicam: Dosage of 1 mL, subcutaneous injection, once daily. Zhongke Baiken Cat Interferon: 1.5 million U, subcutaneous injection, once daily. Kuru Oral Antimicrobial Spray: Oral spray, three times daily. The master of calicivirus/Lysozyme: Targeted genetic engineering, oral administration, twice daily, one capsule each time. High-nutrient wet food: To support Kangkang's overall nutritional needs. 5.4 Special management strategies Kangkang was isolated after discharge to prevent direct contact with other pets, reducing the risk of disease transmission. Additionally, continued oral administration of the master of calicivirus for two treatment courses (8 days each) was prescribed to consolidate the treatment effect. 5.5 Prevention and management of secondary infections During Kangkang's treatment, special attention was given to monitoring and preventing potential secondary infections. The occurrence of secondary infections was successfully avoided through regular examinations and timely treatment adjustments. 5.6 Treatment outcome Following Kangkang's discharge on November 7, 2023, there was a noticeable improvement in his overall health. The results of the five fluorescent PCR tests for the respiratory tract conducted on December 7, 2023 were negative, indicating the success of the treatment. 5.7 Academic and clinical significance of the case This case demonstrates the effectiveness of a comprehensive treatment approach for FCV infection in a clinical setting. It underscores the importance of early diagnosis, comprehensive treatment plans, and strict management strategies in controlling FCV infections. Furthermore, the case proves that high-risk cats, such as those with other health issues, can achieve positive treatment outcomes with appropriate care.
RkJQdWJsaXNoZXIy MjQ4ODYzNA==